CLOPIDAX-A 75 Tablets provide an established, clinically unified combination blood-thinning therapy carefully developed for the continuous management, extended secondary prevention, and long-term stabilization of patients navigating acute coronary syndrome (ACS) or recovering from coronary stenting procedures. When arterial walls undergo structural injury or are fitted with a mechanical stent layout, the body mistakenly treats the site as an active wound, triggering massive platelet recruitment. If left unchecked, rapid clotting cascades can instantly block vital coronary pathways, starving the heart muscle of oxygen. This advanced formulation combines two premier, complementary antiplatelet agents within a single unit to maintain structural vascular patency safely over a regular care routine.
The synchronized combination operates dynamically across two distinct cellular paths:
-
ADP P2Y12 Receptor Blockade (Clopidogrel): It functions as an oral thienopyridine prodrug that requires hepatic conversion to its active metabolite. This active form irreversibly binds to the $P2Y_{12}$ subtype of adenosine diphosphate (ADP) receptors on platelet surfaces, blocking downstream activation of the $GP IIb/IIIa$ glycoprotein receptor complex and keeping the platelet in a non-sticky baseline state.
-
COX-1 Enzyme Inhibition (Aspirin): It works as an irreversible inhibitor of the cyclooxygenase-1 (COX-1) enzyme within blood platelets. By locking this pathway, it completely shuts down the synthesis of Thromboxane $A_2$ ($TXA_2$), a highly potent physiological vasoconstrictor and primary trigger for platelet aggregation. Because platelets lack a nucleus and cannot regenerate enzymes, this double blockade persists around the clock for the entire 7 to 10-day lifespan of the cells.
Key Benefits
-
Synergistic Dual Antiplatelet Therapy (DAPT): Unites two distinct clinical pathways to deliver maximum protection against blood clots where single agents fall short.
-
Vital Cardiac Stent Protection: Significantly lowers the risk of acute stent thrombosis, keeping surgically expanded blood channels open and safe.
-
Proactive Secondary Defense: Statistically proven to lower recurrence rates of myocardial infarction and ischemic stroke in high-risk patient profiles.
-
Gastro-Resistant Core Formulation: Designed to facilitate smooth gastrointestinal transit, helping protect sensitive stomach linings from localized aspirin irritation.
-
Trusted Quality Control: Manufactured under strict pharmaceutical protocols of DH, ensuring exceptional dissolution uniformity and steady structural bioavailability.
Directions for Use
-
Take exactly as directed by your cardiologist, neurologist, or primary care physician.
-
CLOPIDAX-A 75 is strictly administered as a single tablet once daily.
-
Must be taken with or immediately after a main meal (such as breakfast or dinner) with a full glass of plain water. Administering it post-meal is crucial to protect the gastric mucosa and reduce the tracking risk of indigestion.
-
Swallow the tablet whole. Do not crush, break, split, or chew it, as this can destroy the protective film-coating layout.
-
Maintain complete daily consistency; skipping a single dose can cause platelet stickiness metrics to rise rapidly behind risk boundaries.
Safety & Precautions
-
Do not halt usage or modify your dose suddenly without explicit clearance from your cardiologist. Arbitrarily stopping DAPT introduces a critical, life-threatening risk of sudden stent clotting or a major heart attack.
-
Bleeding Risk Warning: As an advanced blood thinner combination, CLOPIDAX-A 75 makes you bruise and bleed more easily. You may encounter routine nosebleeds, bleeding gums, or take longer to stop bleeding from minor cuts. Avoid contact sports, sharp tools, or situations carrying high risk profiles for physical injury.
-
Inform all healthcare professionals (including dentists, surgeons, or podiatrists) that you are taking this medication well in advance of scheduling any procedures; it may need to be paused temporary based on clinical clotting timelines.
-
Contraindicated in Active Bleeding: Do not use if you have an underlying history of active pathological bleeding, such as bleeding stomach ulcers or intracranial hemorrhage.
-
Avoid heavy concurrent consumption of alcohol, as it can severely multiply the risk of developing stomach bleeding cascades.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout until the exact moment of intake to shield the active elements from ambient air degradation.
